(Q36268291)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16185148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Vasoactive intestinal peptide family as a therapeutic target for Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16185148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16185148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Alejo Chorny

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16185148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Mario Delgado

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16185148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Amelia Fernandez-Martin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16185148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Nieves Varela

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16185148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

1 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16185148%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Targets

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16185148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16185148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16185148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

923-929

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16185148%20AND%20SRC:MED&resulttype=core&format=json

The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Alpha-synuclein and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Microglia as mediators of inflammatory and degenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Microglia: a sensor for pathological events in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

The role of glial cells in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Microglial activation and dopamine terminal loss in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit CBP-NF-kappaB interaction in activated microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Inhibition of microglial CD40 expression by pituitary adenylate cyclase-activating polypeptide is mediated by interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Vasoactive Intestinal Polypeptide: Abundant Immunoreactivity in Neural Cell Lines and Normal Nervous Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

A new concept in the pharmacology of neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Hypermotility induced by vasoactive intestinal peptide in the rat: its reciprocal action to cholecystokinin octapeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Expression of mRNA for PACAP and its receptors in intra- and extra-adrenal human pheochromocytomas and their relationship to catecholamine synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Passage of vasoactive intestinal peptide across the blood–brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Effect of middle cerebral artery occlusion on the passage of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

Delivery of peptides and proteins through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.5.923

21 January 2018

Identifiers

DOI

10.1517/14728222.9.5.923

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16185148%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference